Michael A Gorin Steven P Rowe Jody E Hooper Max Kates Hans-Joerg Hammers Zsolt Szabo Martin G Pomper Mohamad E Allaf
10.1016/j.eururo.2016.06.019
Eur Urol
2017 Jan;71(1):145-146.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/27363386/
Antigens, Surface / metabolism Biomarkers, Tumor / metabolism Carcinoma, Renal Cell / diagnostic imaging Glutamate Carboxypeptidase II / metabolism Kidney Neoplasms / diagnostic imaging Lysine / analogs & derivatives Molecular Imaging / methods Positron Emission Tomography Computed Tomography Radiopharmaceuticals / administration & dosage Urea / analogs & derivatives
Antigens, Surface / metabolism Biomarkers, Tumor / metabolism Carcinoma, Renal Cell / diagnostic imaging Glutamate Carboxypeptidase II / metabolism Kidney Neoplasms / diagnostic imaging Lysine / analogs & derivatives Molecular Imaging / methods Positron Emission Tomography Computed Tomography Radiopharmaceuticals / administration & dosage Urea / analogs & derivatives Case Reports Letter Autopsy Carcinoma, Renal Cell / metabolism Carcinoma, Renal Cell / secondary Carcinoma, Renal Cell / therapy Cause of Death Fatal Outcome Humans Kidney Neoplasms / metabolism Kidney Neoplasms / pathology Kidney Neoplasms / therapy Lysine / administration & dosage Male Middle Aged Predictive Value of Tests Urea / administration & dosage Whole Body Imaging 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid Antigens, Surface Biomarkers, Tumor Radiopharmaceuticals Urea FOLH1 protein, human Glutamate Carboxypeptidase II Lysine
PMC5516900
27363386
PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy
2017